Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
9.92
+0.06 (0.61%)
At close: Feb 20, 2026, 4:00 PM EST
9.77
-0.15 (-1.51%)
After-hours: Feb 20, 2026, 7:24 PM EST
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $366.05 million as of February 20, 2026. Its market cap has increased by 381.53% in one year.
Market Cap
366.05M
Enterprise Value
366.47M
1-Year Change
381.53%
Ranking
Category
Stock Price
$9.92
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $366.05M, a decrease of -33.87%. That is a compound annual growth rate of -15.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 366.05M | 598.59% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
| Sep 29, 2023 | 553.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 378.33M |
| LENZ Therapeutics | 376.42M |
| Benitec Biopharma | 373.04M |
| Atea Pharmaceuticals | 367.98M |
| Nautilus Biotechnology | 366.28M |
| Monopar Therapeutics | 365.27M |
| Vanda Pharmaceuticals | 360.56M |
| Aclaris Therapeutics | 349.41M |